Literature DB >> 35562515

Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.

Jingjing Zhu1, Huang Cheng1, Lan Wang1, Weide Xu1, Junqing Wang2, Qing Han1, Jong-Ho Lee3, Linyong Du4, Jianxin Lyu5.   

Abstract

BACKGROUND: Discoidin domain receptor 1 (DDR1), a member of receptor tyrosine kinase, has been implicated in tumor progression. However, the function and underlying mechanism of DDR1 in lung adenocarcinoma (LUAD) progression is unclear. Thus, we explored the molecular regulatory mechanism of DDR1 in the migration of LUAD.
METHODS: Transwell assays, wound healing assays and xenograft tumor assays were performed to study the function of DDR1 in the progression of LUAD. Immunoblotting and quantitative real-time polymerase chain reaction (RT-qPCR) were used to detect the expression levels of genes. Co-immunoprecipitation (co-IP) assays were performed to detect the interaction between DDR1 and AKT. Immunofluorescence and immunohistochemistry assays were used to determine the expression level of proteins in cells and tissues, respectively.
RESULTS: DDR1 expression was significantly higher in LUAD tissues than in normal lung tissues, and the level of DDR1 was inversely correlated with prognosis in patients. We found that DDR1 promoted the migration and invasion of LUAD cells in vitro. Furthermore, ectopic expression of DDR1 in LUAD cells altered EMT-related markers expression. Importantly, the DDR1 protein interacted with AKT and phosphorylated AKT. The AKT inhibitor MK2206 interrupted Snail upregulation in DDR1-overexpressing LUAD cells. Finally, our study revealed that depletion of DDR1 attenuated LUAD cell migration in a tumor xenograft mouse model.
CONCLUSION: Our findings uncovered that a high abundance of DDR1 increased the migration and invasion capability of LUAD cells via the AKT/Snail signaling axis and indicated that DDR1 could be a potential target for treating LUAD.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  DDR1; EMT; Lung adenocarcinoma; Snail

Mesh:

Substances:

Year:  2022        PMID: 35562515     DOI: 10.1007/s11033-022-07509-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  4 in total

1.  Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.

Authors:  Sun Ho Yang; Hyun Ah Baek; Ho Jin Lee; Ho Sung Park; Kyu Yun Jang; Myoung Jae Kang; Dong Geun Lee; Yong Chul Lee; Woo Sung Moon; Myoung Ja Chung
Journal:  Oncol Rep       Date:  2010-08       Impact factor: 3.906

Review 2.  Discoidin Domain Receptors: Potential Actors and Targets in Cancer.

Authors:  Hassan Rammal; Charles Saby; Kevin Magnien; Laurence Van-Gulick; Roselyne Garnotel; Emilie Buache; Hassan El Btaouri; Pierre Jeannesson; Hamid Morjani
Journal:  Front Pharmacol       Date:  2016-03-14       Impact factor: 5.810

3.  Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome.

Authors:  Angela Helfricht; Peter E Thijssen; Magdalena B Rother; Rashmi G Shah; Likun Du; Sanami Takada; Mélanie Rogier; Jacques Moritz; Hanna IJspeert; Chantal Stoepker; Monique M van Ostaijen-Ten Dam; Vincent Heyer; Martijn S Luijsterburg; Anton de Groot; Rianca Jak; Gwendolynn Grootaers; Jun Wang; Pooja Rao; Alfred C O Vertegaal; Maarten J D van Tol; Qiang Pan-Hammarström; Bernardo Reina-San-Martin; Girish M Shah; Mirjam van der Burg; Silvère M van der Maarel; Haico van Attikum
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

Review 4.  Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.

Authors:  Minhui Chen; Anurag K Singh; Elizabeth A Repasky
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.